Anaheim Clinical Trials

Running trials

• Active, not recruiting

  A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  NCT07477704· Phase 2· Source

• Active, not recruiting

  A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

  NCT06660173· Phase 2· Source

• Active, not recruiting

  A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

  NCT06299098· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

  NCT07294898· Phase 1· Source

• Completed

  A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations

  NCT07313761· Phase 1· Source

• Completed

  Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

  NCT07226778· Phase 1· Source

• Completed

  A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity

  NCT07717814· Phase 1· Source

• Completed

  Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

  NCT06585462· Phase 1· Source

• Completed

  Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

  NCT05762471· Phase 1/2· Source

• Completed

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· Phase 3· Source